Skip to main content

Table 3 Factors associated with survival of all patients

From: Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial

Factors Univariate Multivariate
HR 95% CI P HR 95% CI P
Without BD induction 4.730 1.003-22.307 0.050 4.359 0.913-20.823 0.065
Urine protein >3.5 g/24 hour 1.2 0.310-4.647 0.792    
Cardiac stage III 4.118 1.138-14.899 0.031 1.272 0.276-5.864 0.758
Baseline BNP >170 ng/L 2.837 0.814-9.892 0.104    
Troponin-I >0.03 6.494 1.673-25.213 0.007 6.138 1.559-24.170 0.009
The use of MEL 140 3.445 0.730-16.255 0.118    
  1. BD, bortezomib in combination wity dexamethasone; BNP, brain natriuretic peptide; CI, confidence interval; HR, hazard ratio; MEL, melphalan.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us

\